It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
A recent approach to promote central nervous system (CNS) regeneration after injury or disease is direct conversion of somatic cells to neurons. This is achieved by transduction of viral vectors that express neurogenic transcription factors. In this work we propose adult human mucosal olfactory ensheathing glia (hmOEG) as a candidate for direct reprogramming to neurons due to its accessibility and to its well-characterized neuroregenerative capacity. After induction of hmOEG with the single neurogenic transcription factor NEUROD1, the cells under study exhibited morphological and immunolabeling neuronal features, fired action potentials and expressed glutamatergic and GABAergic markers. In addition, after engraftment of transduced hmOEG cells in the mouse hippocampus, these cells showed specific neuronal labeling. Thereby, if we add to the neuroregenerative capacity of hmOEG cultures the conversion to neurons of a fraction of their population through reprogramming techniques, the engraftment of hmOEG and hmOEG-induced neurons could be a procedure to enhance neural repair after central nervous system injury.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 Universidad Francisco de Vitoria, School of Experimental Sciences, Pozuelo de Alarcón, Spain (GRID:grid.449795.2) (ISNI:0000 0001 2193 453X); Columbia University Medical Center, Department of Genetics and Development, New York, USA (GRID:grid.239585.0) (ISNI:0000 0001 2285 2675)
2 Universidad Francisco de Vitoria, School of Experimental Sciences, Pozuelo de Alarcón, Spain (GRID:grid.449795.2) (ISNI:0000 0001 2193 453X)
3 Universidad Autónoma de Madrid, Department of Anatomy, Histology and Neuroscience, School of Medicine, Madrid, Spain (GRID:grid.5515.4) (ISNI:0000 0001 1957 8126)
4 Universidad Francisco de Vitoria, School of Experimental Sciences, Pozuelo de Alarcón, Spain (GRID:grid.449795.2) (ISNI:0000 0001 2193 453X); Universidad Francisco de Vitoria, School of Medicine, Pozuelo de Alarcón, Spain (GRID:grid.449795.2) (ISNI:0000 0001 2193 453X)